SCHRODER INVESTMENT MANAGEMENT GROUP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1086619
London, X0
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,168,233
+$5,842,470 QoQ
Shares Held
24,326
+101.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#242
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. REGN ranks #13 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,410,943 | $99,683,122 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
169,270 | $84,081,485 | |
| 3 | EXEL |
Exelixis, Inc.
|
669,005 | $36,400,560 | |
| 4 | INSM |
INSMED Inc
|
298,372 | $31,812,422 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
95,194 | $28,656,248 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
51,630 | $27,722,728 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
510,787 | $21,917,869 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
379,611 | $21,565,700 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,168,233 | 24,326 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,325,763 | 12,070 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,495,628 | 9,711 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,481,262 | 25,755 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,552,625 | 22,005 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $30,328,878 | 47,820 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $58,071,988 | 81,524 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $99,868,850 | 95,001 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $77,667,962 | 73,897 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $78,313,959 | 81,366 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $37,190,309 | 42,344 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,522,249 | 33,443 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,175,196 | 47,562 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $115,410,942 | 140,459 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $116,827,264 | 161,925 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $101,444,371 | 147,262 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,987,800 | 59,188 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $34,919,601 | 49,998 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,210,509 | 28,836 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $27,314,192 | 45,134 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,695,745 | 26,311 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $11,615,112 | 24,549 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $12,658,930 | 26,203 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,322,624 | 29,159 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,158,922 | 14,686 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,643,583 | 3,366 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||